Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TISOTUMAB VEDOTIN vs TOCILIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TISOTUMAB VEDOTIN vs TOCILIZUMAB: Safety Overview

Metric TISOTUMAB VEDOTIN TOCILIZUMAB
Total FAERS Reports 166 98,443
Deaths Reported 16 9,543
Death Rate 9.6% 9.7%
Hospitalizations 101 24,039
Average Patient Age 50.4 yrs 52.2 yrs
% Female Patients 88.8% 84.5%
Manufacturer SEAGEN INC. CELLTRION USA, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status N/A Prescription